| Address:
|
100 SAW MILL ROAD
|
| City: |
DANBURY |
|
State: |
CT |
|
Zip Code: |
06810 |
| Telephone: |
203-796-5000 |
|
Description of Business
|
Primary SIC Code:
2834 |
| (As filed with the SEC)
|
|
|
We are a specialty biopharmaceutical company focused on the development and
commercialization of innovative treatments for diabetes that may be safer, more
effective and more convenient for patients. We develop our product candidates by
applying our proprietary formulation technologies to existing drugs in order to
improve their therapeutic profiles. Our most advanced program involves
developing proprietary formulations of injectable recombinant human insulin, or
RHI, designed to be more rapid-acting than the "rapid-acting" mealtime insulin
analogs presently used to treat patients with Type 1 and Type 2 diabetes. We,
therefore, refer to these reformulations as our "ultra-rapid-acting" insulin
formulations. In addition to our RHI-based formulations, we are using our
formulation technology to develop new ultra-rapid-acting formulations of insulin
analogs. ... More ... |
| Date |
12-mos
Rolling EPS |
Dividend |
P/E
Ratio |
| 09/2011 | -0.34 | NA | N/E | | 06/2011 | -0.83 | NA | N/E | | 03/2011 | -1.09 | NA | N/E | | 12/2010 | -1.31 | NA | N/E | | 09/2010 | -1.58 | NA | N/E | | 06/2010 | -1.70 | NA | N/E | | 03/2010 | -1.83 | NA | N/E | | 12/2009 | -1.87 | NA | N/E |
Key Financial Ratios and Statistics |
FYE:
09/30 |
| Profitability |
2011 |
Leverage |
2011 |
| Net Inc/Comm Equity | -0.05 | Total Liab/Total Assets | 0.11 | | Net Inc/Total Assets | -0.26 | Total Liab/Inv Cap | 0.12 | | Net Inc/Inv Cap | -0.28 | Total Liab/Comm Equity | 0.02 | | Pretax Inc/Net Sales | NA | Interest Coverage Ratio | NA | | Net Inc/Net Sales | NA | Curr Debt/Equity | NA | | Cash Flow/Net Sales | NA | LTD/Equity | NA | | SG&A/NetSales | NA | Total Debt/Equity | NA |
| Asset Utilization
|
|
Liquidity |
|
| Net Receivables Turnover | NA | Quick Ratio | 11.92 | | Inventory Turnover | NA | Current Ratio | 11.92 | | Inventory Day Sales | NA | Net Rec/Curr Assets | 0.00 | | Net Sales/Work Cap | NA | Inv/Curr Assets | NA | | Net Sales/PP&E | NA | | |
Income Statement (Millions) |
| |
9/30/2011
|
6/30/2011
|
3/31/2011
|
12/31/2010
|
|
Total Revenues(Net Sales)
|
0.00
|
0.00
|
0.00
|
0.00
|
|
Cost of Goods Sold
|
NA
|
NA
|
NA
|
NA
|
|
Selling & Admin Exps
|
2.06
|
2.38
|
2.31
|
2.58
|
|
Operating Income
|
-4.61
|
-5.32
|
-5.21
|
-8.08
|
|
Interest Exp
|
0.00
|
0.00
|
0.00
|
0.00
|
|
Pretax Income
|
4.14
|
-3.95
|
-5.44
|
-5.31
|
|
Other Income
|
8.75
|
1.38
|
-0.23
|
2.78
|
|
Net Income Bef Extraordinary ...
|
NA
|
NA
|
NA
|
NA
|
|
Net Income
|
4.13
|
-3.97
|
-5.44
|
-5.31
|
|
Assets
|
9/30/2011
|
6/30/2011
|
3/31/2011
|
12/31/2010
|
|
Cash & Short Term Investments
|
38.76
|
42.06
|
17.62
|
22.44
|
|
Receivables - Total
|
0.04
|
0.10
|
0.17
|
1.35
|
|
Inventories - Total
|
NA
|
NA
|
NA
|
NA
|
|
Total Current Assets
|
39.20
|
42.65
|
18.56
|
24.76
|
|
Net Property, Plant & Equipment
|
2.25
|
2.43
|
2.56
|
2.81
|
|
Total Assets
|
41.51
|
45.14
|
21.18
|
27.63
|
|
Liabilities
|
|
|
|
|
|
Accounts Payable
|
3.10
|
2.55
|
2.15
|
4.66
|
|
Debt in Current Liabilities
|
NA
|
NA
|
NA
|
NA
|
|
Total Current Liabilities
|
3.29
|
3.23
|
3.06
|
5.35
|
|
Long-Term Debt
|
NA
|
NA
|
NA
|
NA
|
|
Total Liabilities
|
4.43
|
13.26
|
5.18
|
7.39
|
|
Stockholder's Equity
|
|
|
|
|
|
Minority Interest
|
NA
|
NA
|
NA
|
NA
|
|
Preferred Stock
|
0.02
|
0.02
|
NA
|
NA
|
|
Common Stock
|
0.39
|
0.39
|
0.27
|
0.26
|
|
Retained Earnings
|
-175.35
|
-179.48
|
-175.51
|
-170.06
|
|
Treasury Stock
|
NA
|
NA
|
NA
|
NA
|
|
Total Stockholders' Equity
|
37.08
|
31.88
|
16.00
|
20.24
|
|
Total Liabilities and Stockholders' Equity
|
41.51
|
45.14
|
21.18
|
27.63
|
Cash Flow Summary (Millions) |
|
Categories
|
9/30/2011
|
6/30/2011
|
3/31/2011
|
12/31/2010
|
|
Net Cash Provided by Operating Activities
|
-3.32
|
-3.48
|
-4.82
|
-6.63
|
|
Net Cash Provided by Investing Activities
|
-0.03
|
-0.10
|
0.00
|
5.93
|
|
Net Cash Provided by Financing Activities
|
0.05
|
28.02
|
0.09
|
0.06
|
Annual Summary Data (Millions) |
| Year |
Sales |
Net
Income |
EPS |
| 09/2007 | 0.00 | -22.55 | -1.76 | | 09/2008 | 0.00 | -43.36 | -1.94 | | 09/2009 | 0.00 | -43.27 | -1.82 | | 09/2010 | 0.00 | -38.29 | -1.58 | | 09/2011 | 0.00 | -10.59 | -0.34 | | Growth Rates | NaN | -- | -- |
| Type |
Date(Q,M) |
No.
Owners |
Shares
Held (000s) |
%
Own |
| Institutional | 12/31/11 | 43 | 11,620 | 30.02 |
|
Report Date :
1/30/2012
 Copyright
2012, EDGAR Online, Inc. All
rights reserved. Replication or redistribution of EDGAR Online, Inc. content is
expressly prohibited without the prior written consent of EDGAR Online, Inc.
EDGAR Online, Inc. shall not be liable for any errors or delays in the content,
or for any actions taken in reliance thereon.
|
|
|